[go: up one dir, main page]

GB9515557D0 - Viral preparation,immunogens and vacciness - Google Patents

Viral preparation,immunogens and vacciness

Info

Publication number
GB9515557D0
GB9515557D0 GBGB9515557.8A GB9515557A GB9515557D0 GB 9515557 D0 GB9515557 D0 GB 9515557D0 GB 9515557 A GB9515557 A GB 9515557A GB 9515557 D0 GB9515557 D0 GB 9515557D0
Authority
GB
United Kingdom
Prior art keywords
vacciness
immunogens
viral preparation
viral
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9515557.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantab Pharmaceuticals Research Ltd
Original Assignee
Cantab Pharmaceuticals Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Pharmaceuticals Research Ltd filed Critical Cantab Pharmaceuticals Research Ltd
Priority to GBGB9515557.8A priority Critical patent/GB9515557D0/en
Publication of GB9515557D0 publication Critical patent/GB9515557D0/en
Priority to JP8525488A priority patent/JPH11500014A/en
Priority to CA002211743A priority patent/CA2211743A1/en
Priority to EP96903115A priority patent/EP0811057B1/en
Priority to US08/604,165 priority patent/US6287557B1/en
Priority to AT96903115T priority patent/ATE324435T1/en
Priority to DE69636068T priority patent/DE69636068T2/en
Priority to ES96903115T priority patent/ES2264136T3/en
Priority to AU47263/96A priority patent/AU711121B2/en
Priority to EP06007480A priority patent/EP1683858A3/en
Priority to PCT/GB1996/000385 priority patent/WO1996026267A1/en
Priority to AU44455/99A priority patent/AU4445599A/en
Priority to US09/765,870 priority patent/US20020150562A1/en
Priority to US09/917,176 priority patent/US20030091535A1/en
Priority to US10/941,295 priority patent/US20050118192A1/en
Priority to JP2006336186A priority patent/JP2007130022A/en
Pending legal-status Critical Current

Links

GBGB9515557.8A 1995-02-21 1995-07-28 Viral preparation,immunogens and vacciness Pending GB9515557D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB9515557.8A GB9515557D0 (en) 1995-07-28 1995-07-28 Viral preparation,immunogens and vacciness
PCT/GB1996/000385 WO1996026267A1 (en) 1995-02-21 1996-02-21 Viral preparations, vectors, immunogens, and vaccines
DE69636068T DE69636068T2 (en) 1995-02-21 1996-02-21 VIRAL PREPARATIONS, VECTORS, IMMUNOGENS AND VACCINES
AU47263/96A AU711121B2 (en) 1995-02-21 1996-02-21 Viral preparations, vectors, immunogens, and vaccines
EP96903115A EP0811057B1 (en) 1995-02-21 1996-02-21 Viral preparations, vectors, immunogens, and vaccines
US08/604,165 US6287557B1 (en) 1995-02-21 1996-02-21 Methods of gene therapy using herpes viral vectors expressing GM-CSF
AT96903115T ATE324435T1 (en) 1995-02-21 1996-02-21 VIRAL PREPARATIONS, VECTORS, IMMUNOGENS AND VACCINES
JP8525488A JPH11500014A (en) 1995-02-21 1996-02-21 Viral preparations, vectors, immunogens, and vaccines
ES96903115T ES2264136T3 (en) 1995-02-21 1996-02-21 VIRAL PREPARATIONS, VECTORS, IMMUNOGENS AND THEIR VACCINES.
CA002211743A CA2211743A1 (en) 1995-02-21 1996-02-21 Viral preparations, vectors, immunogens, and vaccines
EP06007480A EP1683858A3 (en) 1995-02-21 1996-02-21 Viral preparations, vectors, immunogens, and vaccines
AU44455/99A AU4445599A (en) 1995-02-21 1999-08-12 Viral preparations, vectors, immunogens, and vaccines
US09/765,870 US20020150562A1 (en) 1995-02-21 2001-01-19 Viral preparations, vectors, immunogens, and vaccines
US09/917,176 US20030091535A1 (en) 1995-02-21 2001-07-27 Viral preparations, vectors, immunogens, and vaccines
US10/941,295 US20050118192A1 (en) 1995-02-21 2004-09-14 Viral preparations, vectors, immunogens, and vaccines
JP2006336186A JP2007130022A (en) 1995-02-21 2006-12-13 Viral preparation, vector, immunogen and vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9515557.8A GB9515557D0 (en) 1995-07-28 1995-07-28 Viral preparation,immunogens and vacciness

Publications (1)

Publication Number Publication Date
GB9515557D0 true GB9515557D0 (en) 1995-09-27

Family

ID=10778453

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9515557.8A Pending GB9515557D0 (en) 1995-02-21 1995-07-28 Viral preparation,immunogens and vacciness

Country Status (1)

Country Link
GB (1) GB9515557D0 (en)

Similar Documents

Publication Publication Date Title
GB9513261D0 (en) Vaccines
AP9701060A0 (en) Hepatitis B vaccine
EP0813365A4 (en) Immunoisolation
GB9503240D0 (en) Preparation
HUP9602745A3 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharm
EP1041888A4 (en) Anti-retroviral immunogens, preparation and use
EP0750845A3 (en) Quick-fermented feed, its preparation and uses
PL321686A1 (en) Trensdermal preparation
ZA969625B (en) 25-Hydroxy-16-ene-26, 27-bishomo-cholecalciferols
GR3034261T3 (en) 14alpha,17alpha-c2-bridged 19-nor-progesterone derivatives
GB9515557D0 (en) Viral preparation,immunogens and vacciness
GB2299969B (en) Security envelope
GB9423663D0 (en) Viral preparations, immunogens, and vaccines
AU2517895A (en) Hiv polyprotein immunogens
MD956F1 (en) N-carboxyaryl-N',N'-dimethylthiouûreas preparation process
GB9503395D0 (en) Viral,preparations,immunogens,and vaccines
GB9603322D0 (en) Viral preparations,immunogens and vaccines
ZA968953B (en) 24-homo-26,27-hexafluoro-cholecalciferols
GB9508704D0 (en) Virus
ZA967198B (en) Vaccines.
GB9413517D0 (en) Viral vaccines
HK1016577A1 (en) 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
GB9504856D0 (en) Compound,preparation and use
GB9514118D0 (en) Novel attenvated HIV vaccine
ZA962036B (en) Vaccines